Sun SY - Search Results

1

Spatially resolved subcellular protein-protein interactomics in drug-perturbed lung-cancer cultures and tissues.

Cai S, Hu T, Venkataraman A, Rivera Moctezuma FG, Ozturk E, Zhang N, Wang M, Zvidzai T, Das S, Pillai A, Schneider F, Ramalingam SS, Oh YT, Sun SY, Coskun AF. Cai S, et al. Among authors: sun sy. Nat Biomed Eng. 2024 Oct 30. doi: 10.1038/s41551-024-01271-x. Online ahead of print. Nat Biomed Eng. 2024. PMID: 39478233

2

Gene expression profiling of non-small cell lung cancer.

Singhal S, Miller D, Ramalingam S, Sun SY. Singhal S, et al. Among authors: sun sy. Lung Cancer. 2008 Jun;60(3):313-24. doi: 10.1016/j.lungcan.2008.03.007. Epub 2008 Apr 25. Lung Cancer. 2008. PMID: 18440087 Free PMC article. Review.

3

Overcoming mTOR inhibition-induced paradoxical activation of survival signaling pathways enhances mTOR inhibitors' anticancer efficacy.

Wang X, Hawk N, Yue P, Kauh J, Ramalingam SS, Fu H, Khuri FR, Sun SY. Wang X, et al. Among authors: sun sy. Cancer Biol Ther. 2008 Dec;7(12):1952-8. doi: 10.4161/cbt.7.12.6944. Epub 2008 Dec 8. Cancer Biol Ther. 2008. PMID: 18981735 Free PMC article.

4

Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.

Fan S, Ramalingam SS, Kauh J, Xu Z, Khuri FR, Sun SY. Fan S, et al. Among authors: sun sy. Cancer Biol Ther. 2009 Aug;8(15):1463-9. doi: 10.4161/cbt.8.15.8960. Epub 2009 Aug 8. Cancer Biol Ther. 2009. PMID: 19483468 Free PMC article.

5

The role of cetuximab in the management of non-small-cell lung cancer.

Owonikoko TK, Sun SY, Ramalingam SS. Owonikoko TK, et al. Among authors: sun sy. Clin Lung Cancer. 2009 Jul;10(4):230-8. doi: 10.3816/CLC.2009.n.031. Clin Lung Cancer. 2009. PMID: 19632939 Review.

6

Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer.

Ramalingam SS, Harvey RD, Saba N, Owonikoko TK, Kauh J, Shin DM, Sun SY, Strychor S, Tighiouart M, Egorin MJ, Fu H, Khuri FR. Ramalingam SS, et al. Among authors: sun sy. Cancer. 2010 Aug 15;116(16):3903-9. doi: 10.1002/cncr.25264. Cancer. 2010. PMID: 20564143 Free PMC article. Clinical Trial.

7

ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.

Oh YT, Liu X, Yue P, Kang S, Chen J, Taunton J, Khuri FR, Sun SY. Oh YT, et al. Among authors: sun sy. J Biol Chem. 2010 Dec 31;285(53):41310-9. doi: 10.1074/jbc.M110.153775. Epub 2010 Nov 2. J Biol Chem. 2010. PMID: 21044953 Free PMC article.

8

c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.

Fu L, Lin YD, Elrod HA, Yue P, Oh Y, Li B, Tao H, Chen GZ, Shin DM, Khuri FR, Sun SY. Fu L, et al. Among authors: sun sy. Mol Cancer. 2010 Dec 20;9:315. doi: 10.1186/1476-4598-9-315. Mol Cancer. 2010. PMID: 21172010 Free PMC article.

9

Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression.

Dhandapani L, Yue P, Ramalingam SS, Khuri FR, Sun SY. Dhandapani L, et al. Among authors: sun sy. Cancer Res. 2011 Aug 1;71(15):5245-54. doi: 10.1158/0008-5472.CAN-10-4180. Epub 2011 Jun 17. Cancer Res. 2011. PMID: 21685476 Free PMC article.

10

The combination of RAD001 and NVP-BEZ235 exerts synergistic anticancer activity against non-small cell lung cancer in vitro and in vivo.

Xu CX, Li Y, Yue P, Owonikoko TK, Ramalingam SS, Khuri FR, Sun SY. Xu CX, et al. Among authors: sun sy. PLoS One. 2011;6(6):e20899. doi: 10.1371/journal.pone.0020899. Epub 2011 Jun 14. PLoS One. 2011. PMID: 21695126 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

692 results

Search Page

Filters